DeepNewz, mobile.

People-sourced. AI-powered. Unbiased News.

Screenshot of DeepNewz app showing story detail view.

Screenshot of DeepNewz app showing story list view.

Breakthrough Therapy Designation News

FDA Grants Breakthrough Therapy Designations to Bristol-Myers Squibb’s Izalontamab Brengitecan, Durvalumab, Jemperli, and Approves Datopotamab Deruxtecan

FDA Grants Breakthrough Therapy Designations to Bristol-Myers Squibb’s Izalontamab Brengitecan, Durvalumab, Jemperli, and Approves Datopotamab Deruxtecan

5

6 months ago

How many AI-generated drugs will be approved by the FDA by the end of 2030?

Jun 11, 2:21 PMDec 31, 11:59 PM

7612

OptionProbability

1 - 5

0

6 - 10

11 - 20

21 - 50

51 - 100

Above 100

47

21

12

5

5

5

5

Any province legalizes psilocybin for recreational use?

Feb 1, 11:40 AMDec 17, 11:59 PM

9.95%chance

2110

OptionVotes

YES

NO

1005

999

Latest stories

Aug 20, 2025
Aug 20, 2025
Health
Pharma
Science
FDA Grants Breakthrough Therapy Designations to Bristol-Myers Squibb’s Izalontamab Brengitecan, Durvalumab, Jemperli, and Approves Datopotamab Deruxtecan
Authors
5
6 months ago

Join our channels

Get the latest stories live on any device.

WhatsApp
Top Stories
Join
Telegram
Top Stories
Join